Yi Zhao

4.6k total citations
110 papers, 3.1k citations indexed

About

Yi Zhao is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yi Zhao has authored 110 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Neurology, 44 papers in Molecular Biology and 29 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yi Zhao's work include Parkinson's Disease Mechanisms and Treatments (43 papers), Nuclear Receptors and Signaling (17 papers) and RNA regulation and disease (12 papers). Yi Zhao is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (43 papers), Nuclear Receptors and Signaling (17 papers) and RNA regulation and disease (12 papers). Yi Zhao collaborates with scholars based in Singapore, United States and China. Yi Zhao's co-authors include Eng‐King Tan, Pavanni Ratnagopal, Stephanie Fook‐Chong, Hui Shen, Yuen Yih, Martin C. S. Wong, Kenneth Yew, Patrick Ho, Y. Yih and Louis C.S. Tan and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Yi Zhao

110 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Zhao Singapore 31 1.5k 990 799 546 474 110 3.1k
Kensuke Murakami Japan 23 595 0.4× 1.2k 1.2× 517 0.6× 713 1.3× 387 0.8× 76 2.7k
Henri J. Huttunen Finland 32 364 0.2× 1.8k 1.9× 599 0.7× 570 1.0× 1.1k 2.2× 62 4.0k
Yuiko Morita‐Fujimura United States 26 611 0.4× 1.8k 1.8× 514 0.6× 739 1.4× 384 0.8× 39 3.3k
Ki Whan Hong South Korea 36 296 0.2× 1.3k 1.3× 364 0.5× 514 0.9× 885 1.9× 109 3.6k
Kazuhiro Nakaso Japan 27 761 0.5× 1.3k 1.3× 542 0.7× 249 0.5× 386 0.8× 65 2.6k
Yu Yamazaki Japan 22 311 0.2× 913 0.9× 337 0.4× 828 1.5× 1.5k 3.1× 69 2.9k
Gyung Whan Kim South Korea 27 287 0.2× 1.2k 1.2× 460 0.6× 523 1.0× 405 0.9× 62 2.5k
Xiaofan Jiang China 29 330 0.2× 1.4k 1.4× 355 0.4× 454 0.8× 423 0.9× 110 2.9k
Shin’ichi Shoji Japan 26 362 0.2× 953 1.0× 371 0.5× 245 0.4× 868 1.8× 83 2.0k
Chikako Nito Japan 26 449 0.3× 902 0.9× 366 0.5× 668 1.2× 256 0.5× 67 2.4k

Countries citing papers authored by Yi Zhao

Since Specialization
Citations

This map shows the geographic impact of Yi Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Zhao more than expected).

Fields of papers citing papers by Yi Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Zhao. The network helps show where Yi Zhao may publish in the future.

Co-authorship network of co-authors of Yi Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Zhao. A scholar is included among the top collaborators of Yi Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Zhao. Yi Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Jian, et al.. (2023). Causal associations of gut microbiota and metabolites on sepsis: a two-sample Mendelian randomization study. Frontiers in Immunology. 14. 1190230–1190230. 7 indexed citations
3.
Chen, Zhiyong, Zheyu Xu, Yi Jayne Tan, et al.. (2020). Phenotypic bases of NOTCH2NLC GGC expansion positive neuronal intranuclear inclusion disease in a Southeast Asian cohort. Clinical Genetics. 98(3). 274–281. 29 indexed citations
4.
Tan, Yi Jayne, Yi Zhao, Dede Liana Heng, et al.. (2020). <i>SNCA</i> Rep1 microsatellite length influences non-motor symptoms in early Parkinson&#x2019;s disease. Aging. 12(20). 20880–20887. 3 indexed citations
5.
Ahmad‐Annuar, Azlina, Huihua Li, Yi Zhao, et al.. (2016). PARK16 is associated with PD in the Malaysian population. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 171(6). 839–847. 13 indexed citations
6.
Ma, Dongrui, et al.. (2016). Derivation of human induced pluripotent stem cell (iPSC) line with LRRK2 gene R1398H variant in Parkinson's disease. Stem Cell Research. 18. 48–50. 7 indexed citations
7.
Chen, Chiung‐Mei, et al.. (2013). Genetic Variations of GAK in Two Chinese Parkinson’s Disease Populations: A Case-Control Study. PLoS ONE. 8(6). e67506–e67506. 17 indexed citations
8.
Liu, Yan, Chee Kian Tham, Min Hoe Chew, et al.. (2013). Serum methylation levels ofTAC1. SEPT9andEYA4as diagnostic markers for early colorectal cancers: a pilot study. Biomarkers. 18(5). 399–405. 30 indexed citations
9.
Zhao, Yi, Jasinda H. Lee, Michelle Tan, et al.. (2011). Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's disease. Neurochemistry International. 58(7). 820–825. 14 indexed citations
10.
Tan, Eng‐King, Chun‐Hwei Tai, Louis C.S. Tan, et al.. (2009). Non-synonymous GIGYF2 variants in Parkinson’s disease from two Asian populations. Human Genetics. 126(3). 425–430. 16 indexed citations
11.
Tan, Eng‐King, et al.. (2008). Pathogenicity of LRRK2 P755L variant in Parkinson's disease. Movement Disorders. 23(5). 734–736. 7 indexed citations
12.
Tan, Eng‐King, Yi Zhao, Louis C.S. Tan, et al.. (2007). Analysis of LRRK2 Gly2385Arg genetic variant in non‐Chinese Asians. Movement Disorders. 22(12). 1816–1818. 24 indexed citations
13.
Tan, Eng‐King, et al.. (2007). SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese. Neurobiology of Aging. 30(7). 1048–1051. 59 indexed citations
14.
Tan, Eng‐King, et al.. (2007). Case control analysis of LRRK2 Gly2385Arg in Alzheimer's disease. Neurobiology of Aging. 30(3). 501–502. 16 indexed citations
16.
Tan, Eng‐King, Stephanie Fook‐Chong, Hui Shen, et al.. (2006). Exploring an interaction of adenosine A2A receptor variability with coffee and tea intake in Parkinson's disease. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 141B(6). 634–636. 17 indexed citations
17.
Zhao, Yi, E. Chua, Hai‐Yang Law, et al.. (2006). Genetic analysis of SCA2, 3 and 17 in idiopathic Parkinson's disease. Neuroscience Letters. 403(1-2). 11–14. 22 indexed citations
18.
Tan, Eng‐King, S.Y. Lum, Hui Shen, et al.. (2003). Monoamine oxidase B polymorphism, cigarette smoking and risk of Parkinson's disease: A study in an Asian population. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 120B(1). 58–62. 27 indexed citations
19.
Tan, Eng‐King, Hui Shen, S.Y. Lum, et al.. (2002). Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability. Neuroscience Letters. 336(1). 70–72. 59 indexed citations
20.
Adachi, Kazuhiko, Yi Zhao, Takamasa Yamaguchi, & Saul Surrey. (2000). Assembly of γ- with α-Globin Chains to Form Human Fetal Hemoglobin in Vitro and in Vivo. Journal of Biological Chemistry. 275(17). 12424–12429. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026